Data from multiple sources - Curated by Toby Galbraith - Last updated 04 January 2017

Latest news articles

Added 2 months ago Drug news

FDA approves Eucrisa (crisaborole) ointment 2% for the treatment of mild to moderate atopic dermatitis.- Pfizer

Pfizer Inc.has announced that the FDA approved Eucrisa (crisaborole) ointment 2%, a novel non-steroidal topical phosphodieterase-4 (PDE-4) inhibitor for the...

Added 2 months ago Drug news

Dupixent (dupilumab) filed in the EU for moderate-to-severe atopic dermatitis- Sanofi/Regeneron Pharma

Sanofi and Regeneron Pharmaceuticals announced that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA)...

Added 3 months ago Drug news

Auvi-Q (epinephrine injection) auto-injector for anaphylaxis to be reintroduced to the US market- Kaléo

Kaléo has announced that it will reintroduce Auvi-Q (epinephrine injection) auto-injector to the U.S. market in the first half of...

View all news articles

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria

Visit Chronic Spontaneous Urticaria (CSU)

Cystic Fibrosis

View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines

Visit Cystic Fibrosis


BSACI guideline for the management of chronic urticaria and angioedema

This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care...

Added 1 year ago

Management of allergy to penicillins and other beta-lactams

The Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI) and an expert panel have...

Added 2 years ago

Drug allergy: diagnosis and management

In view of the variation in provision of care for people with drug allergy, the scope of this guideline identified...

Added 2 years ago

View all guidelines

Journal articles

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.

Importance: The house dust mite (HDM) sublingual allergen immunotherapy (SLIT) tablet is a potential novel treatment option for HDM allergy-related...

Added 9 months ago

View all journal articles